Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

United Therapeutics Revenue 2010-2024 | UTHR

United Therapeutics annual/quarterly revenue history and growth rate from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • United Therapeutics revenue for the quarter ending March 31, 2024 was $0.678B, a 33.7% increase year-over-year.
  • United Therapeutics revenue for the twelve months ending March 31, 2024 was $2.498B, a 26.09% increase year-over-year.
  • United Therapeutics annual revenue for 2023 was $2.328B, a 20.2% increase from 2022.
  • United Therapeutics annual revenue for 2022 was $1.936B, a 14.88% increase from 2021.
  • United Therapeutics annual revenue for 2021 was $1.686B, a 13.63% increase from 2020.
  
United Therapeutics Annual Revenue
(Millions of US $)
2023 $2,328
2022 $1,936
2021 $1,686
2020 $1,483
2019 $1,449
2018 $1,628
2017 $1,725
2016 $1,599
2015 $1,466
2014 $1,289
2013 $1,117
2012 $916
2011 $743
2010 $593
2009 $359
United Therapeutics Quarterly Revenue
(Millions of US $)
2024-03-31 $678
2023-12-31 $615
2023-09-30 $609
2023-06-30 $597
2023-03-31 $507
2022-12-31 $492
2022-09-30 $516
2022-06-30 $467
2022-03-31 $462
2021-12-31 $415
2021-09-30 $445
2021-06-30 $447
2021-03-31 $379
2020-12-31 $385
2020-09-30 $380
2020-06-30 $362
2020-03-31 $356
2019-12-31 $311
2019-09-30 $402
2019-06-30 $374
2019-03-31 $363
2018-12-31 $381
2018-09-30 $413
2018-06-30 $445
2018-03-31 $389
2017-12-31 $465
2017-09-30 $446
2017-06-30 $445
2017-03-31 $371
2016-12-31 $409
2016-09-30 $408
2016-06-30 $413
2016-03-31 $369
2015-12-31 $405
2015-09-30 $386
2015-06-30 $347
2015-03-31 $328
2014-12-31 $346
2014-09-30 $330
2014-06-30 $323
2014-03-31 $289
2013-12-31 $289
2013-09-30 $302
2013-06-30 $281
2013-03-31 $245
2012-12-31 $244
2012-09-30 $242
2012-06-30 $226
2012-03-31 $204
2011-12-31 $195
2011-09-30 $202
2011-06-30 $184
2011-03-31 $163
2010-12-31 $161
2010-09-30 $169
2010-06-30 $135
2010-03-31 $129
2009-12-31 $98
2009-09-30 $97
2009-06-30 $84
2009-03-31 $80
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $12.095B $2.328B
United Therapeutics Corporation markets four medicines in the United States to treat pulmonary arterial hypertension (PAH): Remodulin, an injectable formulation of treprostinil, Orenitram, an oral version of treprostinil, Tyvaso, an inhaled version of treprostinil, and Adcirca (tadalafil; also sold by Eli Lilly as Cialis for erectile dysfunction) tablets.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $79.067B 32.15
Chugai Pharmaceutical (CHGCY) Japan $51.455B 23.00
Takeda Pharmaceutical (TAK) Japan $42.377B 8.58
Merck (MKGAF) Germany $22.694B 22.00
Astellas Pharma (ALPMY) Japan $17.735B 28.00
Sandoz Group AG (SDZNY) Switzerland $15.417B 0.00
Neurocrine Biosciences (NBIX) United States $14.290B 39.12
Shionogi (SGIOY) Japan $13.866B 12.05
Catalent (CTLT) United States $10.064B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.683B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.918B 7.61
Revolution Medicines (RVMD) United States $6.499B 0.00
Ionis Pharmaceuticals (IONS) United States $5.723B 0.00
Orion OYJ (ORINY) Finland $5.645B 23.81
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.396B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.512B 0.00
Alpine Immune Sciences (ALPN) United States $4.457B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.982B 0.00
Summit Therapeutics (SMMT) United States $3.152B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.110B 0.00
Corcept Therapeutics (CORT) United States $2.897B 26.25
PTC Therapeutics (PTCT) United States $2.582B 0.00
Dyne Therapeutics (DYN) United States $2.567B 0.00
Indivior (INDV) United States $2.416B 11.45
Recursion Pharmaceuticals (RXRX) United States $2.349B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.109B 12.05
Evotec AG (EVO) Germany $2.009B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.968B 19.15
Fusion Pharmaceuticals (FUSN) Canada $1.832B 0.00
Ardelyx (ARDX) United States $1.827B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.768B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.592B 27.86
Soleno Therapeutics (SLNO) United States $1.511B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.457B 0.00
Pacira BioSciences (PCRX) United States $1.400B 13.31
4D Molecular Therapeutics (FDMT) United States $1.323B 0.00
Xencor (XNCR) United States $1.313B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.313B 0.00
Enliven Therapeutics (ELVN) United States $1.129B 0.00
Collegium Pharmaceutical (COLL) United States $1.112B 6.65
Cronos Group (CRON) Canada $1.108B 0.00
Cassava Sciences (SAVA) United States $1.104B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.027B 16.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.994B 0.00
Ocular Therapeutix (OCUL) United States $0.974B 0.00
USANA Health Sciences (USNA) United States $0.913B 14.93
Relay Therapeutics (RLAY) United States $0.902B 0.00
ProKidney (PROK) United States $0.899B 0.00
ARS Pharmaceuticals (SPRY) United States $0.860B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.758B 0.00
Sage Therapeutics (SAGE) United States $0.705B 0.00
Silence Therapeutics (SLN) United Kingdom $0.668B 0.00
Savara (SVRA) United States $0.667B 0.00
Lyell Immunopharma (LYEL) United States $0.665B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.659B 0.00
Altimmune (ALT) United States $0.629B 0.00
Exscientia (EXAI) United Kingdom $0.620B 0.00
Harrow (HROW) United States $0.563B 0.00
Siga Technologies (SIGA) United States $0.555B 7.09
OmniAb (OABI) United States $0.532B 0.00
Verve Therapeutics (VERV) United States $0.523B 0.00
KalVista Pharmaceuticals (KALV) United States $0.507B 0.00
Bioventus (BVS) United States $0.503B 19.24
Larimar Therapeutics (LRMR) United States $0.502B 0.00
Korro Bio (KRRO) United States $0.489B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.478B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.472B 0.00
Lexeo Therapeutics (LXEO) United States $0.460B 0.00
Heron Therapeutics (HRTX) United States $0.452B 0.00
Esperion Therapeutics (ESPR) United States $0.436B 0.00
Organogenesis (ORGO) United States $0.394B 74.25
Tourmaline Bio (TRML) United States $0.391B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.386B 0.00
Nanobiotix S.A (NBTX) France $0.345B 0.00
Fractyl Health (GUTS) United States $0.342B 0.00
Nektar Therapeutics (NKTR) United States $0.336B 0.00
Black Diamond Therapeutics (BDTX) United States $0.306B 0.00
Nature's Sunshine Products (NATR) United States $0.295B 18.76
Xeris Biopharma Holdings (XERS) United States $0.294B 0.00
Aquestive Therapeutics (AQST) United States $0.293B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.283B 0.00
ESSA Pharma (EPIX) Canada $0.275B 0.00
Metagenomi (MGX) United States $0.255B 0.00
Pyxis Oncology (PYXS) United States $0.248B 0.00
Aldeyra Therapeutics (ALDX) United States $0.248B 0.00
Akebia Therapeutics (AKBA) United States $0.247B 0.00
Foghorn Therapeutics (FHTX) United States $0.225B 0.00
Eliem Therapeutics (ELYM) United States $0.222B 0.00
Conduit Pharmaceuticals (CDT) United States $0.219B 0.00
Avita Medical (RCEL) United States $0.212B 0.00
Profound Medical (PROF) Canada $0.209B 0.00
Zevra Therapeutics (ZVRA) United States $0.202B 0.00
Century Therapeutics (IPSC) United States $0.200B 0.00
Acrivon Therapeutics (ACRV) United States $0.196B 0.00
Adherex Technologies (FENC) United States $0.191B 232.67
Galectin Therapeutics (GALT) United States $0.189B 0.00
Incannex Healthcare (IXHL) Australia $0.184B 0.00
Telomir Pharmaceuticals (TELO) United States $0.184B 0.00
Achieve Life Sciences (ACHV) Canada $0.179B 0.00
Innate Pharma SA (IPHYF) France $0.176B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.170B 0.00
MediWound (MDWD) Israel $0.169B 0.00
Prelude Therapeutics (PRLD) United States $0.168B 0.00
VAXART, INC (VXRT) United States $0.167B 0.00
CytoDyn (CYDY) United States $0.164B 0.00
Cardiol Therapeutics (CRDL) Canada $0.158B 0.00
Elite Pharmaceuticals (ELTP) United States $0.149B 13.99
OptiNose (OPTN) United States $0.134B 0.00
Karyopharm Therapeutics (KPTI) United States $0.133B 0.00
Regulus Therapeutics (RGLS) United States $0.132B 0.00
Context Therapeutics (CNTX) United States $0.127B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.124B 8.27
FibroGen (FGEN) United States $0.118B 0.00
Citius Pharmaceuticals (CTXR) United States $0.113B 0.00
PMV Pharmaceuticals (PMVP) United States $0.111B 0.00
Relmada Therapeutics (RLMD) United States $0.105B 0.00
Vivani Medical (VANI) United States $0.105B 0.00
ProPhase Labs (PRPH) United States $0.098B 0.00
Assertio Holdings (ASRT) United States $0.096B 4.39
AlloVir (ALVR) United States $0.086B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
SCYNEXIS (SCYX) United States $0.085B 1.20
Aclaris Therapeutics (ACRS) United States $0.084B 0.00
Protara Therapeutics (TARA) United States $0.076B 0.00
Tempest Therapeutics (TPST) United States $0.075B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.073B 0.00
Journey Medical (DERM) United States $0.072B 0.00
Jaguar Animal Health (JAGX) United States $0.070B 0.00
Champions Oncology (CSBR) United States $0.065B 0.00
Mural Oncology (MURA) Ireland $0.065B 0.00
Carisma Therapeutics (CARM) United States $0.058B 0.00
Inotiv (NOTV) United States $0.058B 0.00
Nutriband (NTRB) United States $0.055B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.053B 0.00
BioLineRx (BLRX) Israel $0.049B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.048B 0.00
Gain Therapeutics (GANX) United States $0.047B 0.00
ElectroCore (ECOR) United States $0.044B 0.00
CASI Pharmaceuticals (CASI) China $0.044B 0.00
Natural Alternatives (NAII) United States $0.042B 0.00
Unicycive Therapeutics (UNCY) United States $0.041B 0.00
VYNE Therapeutics (VYNE) United States $0.040B 0.00
Rafael Holdings (RFL) United States $0.038B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.037B 0.00
NRx Pharmaceuticals (NRXP) United States $0.035B 0.00
Viracta Therapeutics (VIRX) United States $0.033B 0.00
Surrozen (SRZN) United States $0.032B 0.00
JanOne (JAN) United States $0.031B 0.00
Lipocine (LPCN) United States $0.030B 0.00
DURECT (DRRX) United States $0.030B 0.00
Enlivex Therapeutics (ENLV) Israel $0.026B 0.00
Oncternal Therapeutics (ONCT) United States $0.026B 0.00
Iterum Therapeutics (ITRM) Ireland $0.025B 0.00
Aptorum Group (APM) United Kingdom $0.024B 0.00
TherapeuticsMD (TXMD) United States $0.024B 0.00
PolyPid (PYPD) Israel $0.023B 0.00
Lyra Therapeutics (LYRA) United States $0.022B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.021B 0.00
MEI Pharma (MEIP) United States $0.021B 0.79
Talphera (TLPH) United States $0.021B 0.00
BioVie (BIVI) United States $0.020B 0.00
Indaptus Therapeutics (INDP) United States $0.019B 0.00
Alaunos Therapeutics (TCRT) United States $0.019B 0.00
Minerva Neurosciences (NERV) United States $0.018B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.017B 0.00
GlycoMimetics (GLYC) United States $0.017B 0.00
CERo Therapeutics Holdings (CERO) United States $0.017B 0.00
Traws Pharma (TRAW) United States $0.017B 0.00
Mannatech (MTEX) United States $0.015B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.015B 0.00
Redhill Biopharma (RDHL) Israel $0.014B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.014B 0.00
Inhibikase Therapeutics (IKT) United States $0.013B 0.00
Cosmos Health (COSM) Greece $0.012B 0.00
Dominari Holdings (DOMH) United States $0.012B 0.00
Avalo Therapeutics (AVTX) United States $0.011B 0.00
Biomerica (BMRA) United States $0.010B 0.00
Plus Therapeutics (PSTV) United States $0.010B 0.00
Molecular Templates (MTEM) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Universe Pharmaceuticals INC (UPC) China $0.009B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Ainos (AIMD) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Heatwurx (PCSA) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.005B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
TransCode Therapeutics (RNAZ) United States $0.005B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
Clever Leaves Holdings (CLVR) Canada $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.004B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Avenue Therapeutics (ATXI) United States $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 4.98
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 34.78